A comparison of peritonitis rates from the United States Renal Data System database: CAPD versus continuous cycling peritoneal dialysis patients

2005 ◽  
Vol 45 (2) ◽  
pp. 372-380 ◽  
Author(s):  
Than N. Oo ◽  
Tricia L. Roberts ◽  
Allan J. Collins
2020 ◽  
Vol 2 (3) ◽  
pp. 267-275 ◽  
Author(s):  
Paul N. Bennett ◽  
Wael F. Hussein ◽  
Kimberly Matthews ◽  
Mike West ◽  
Erick Smith ◽  
...  

2017 ◽  
Vol 37 (1) ◽  
pp. 85-93 ◽  
Author(s):  
Suzanne M. Boyle ◽  
Yimei Li ◽  
F. Perry Wilson ◽  
Joel D. Glickman ◽  
Harold I. Feldman

BackgroundTotal body water (V) is an imprecise metric for normalization of dialytic urea clearance (Kt). This poses a risk of early mortality/technique failure (TF). We examined differences in the distribution of peritoneal Kt/V when V was calculated with actual weight (AW), ideal weight (IW), and adjusted weight (ADW). We also examined the associations of these Kt/V measurements, Kt/body surface area (BSA), and non-normalized Kt with mortality and TF.MethodsThis is a retrospective cohort study of 534 incident peritoneal dialysis (PD) patients from the Dialysis Morbidity and Mortality Study Wave 2 linked with United States Renal Data System through 2010. Using Cox-proportional hazard models, we examined the relationship of several normalization strategies for peritoneal urea clearance, including Kt/VAW, Kt/VIW, Kt/VADW, Kt/BSA, and non-normalized Kt, with the outcomes of mortality and TF. Harrell's c-statistics were used to assess the relative predictive ability of clearance metrics for mortality and TF. The distributions of Kt/VAW, KT/VIW, and KT/VADWwere compared within and between body mass index (BMI) strata.ResultsMedian patient age: 59 (54% male; 72% white; 91% continuous ambulatory PD [CAPD]). Median 24-hour urine volume: 700 mL; median estimated glomerular filtration rate (eGFR) at initiation: 7.15 mL/min/1.73 m2. Technique failure and transplant-censored mortality at 5 years: 37%. Death and transplant-censored TF at 5 years: 60%. There were no significant differences in initial eGFR and 24-hour urine volume across BMI strata. There were statistically significant differences in each Kt/V calculation within the underweight, overweight, and obese strata. After adjustment, there were no significant differences in the hazard ratios (HRs) for TF/mortality for each clearance calculation. Harrell's c-statistics for mortality for each clearance calculation were 0.78, and for TF, 0.60 – 0.61.ConclusionsPeritoneal urea clearances are sensitive to subtle changes in the estimation of V. However, there were no detectable significant associations of Kt/VAW, Kt/VIW, Kt/VADW, Kt/BSA, or Kt with TF or mortality.


1999 ◽  
Vol 55 (5) ◽  
pp. 1998-2010 ◽  
Author(s):  
Diane L. Frankenfield ◽  
◽  
Barbara F. Prowant ◽  
Michael J. Flanigan ◽  
Pamela R. Frederick ◽  
...  

2012 ◽  
Vol 32 (3) ◽  
pp. 322-331 ◽  
Author(s):  
Rajnish Mehrotra ◽  
Kenneth Story ◽  
Steven Guest ◽  
Michelle Fedunyszyn

BackgroundThe adjusted 5-year survival for dialysis patients in the United States is 33%–35%, and patients treated with peritoneal dialysis (PD) have a high risk of transfer to hemodialysis (HD). No data are available on the effect of neighborhood characteristics or regional differences on the outcomes of PD patients in the United States.MethodsWe analyzed the relationships of selected patient demographics, socio-economic characteristics of the dialysis unit's neighborhood, “rurality,” and geographic location with transfer to HD and with a composite outcome of transfer to HD or death, for all PD patients in the United States who, between 2004 and 2009, used supplies manufactured by Baxter Healthcare ( n = 58 700).ResultsOver a median follow-up of 18.7 months, 29% of patients transferred to HD (median time to HD transfer: 49 months), and 54% reached the composite outcome. More than 20% of the events occurred within the first 90 days of PD start. The risk for each of the study outcomes was higher for patients who had received any previous treatment with HD, for those treated in units located in areas with a higher proportion of black residents, and for those living in remote rural areas. Furthermore, the risk for reaching either of the study outcomes was consistently lower for patients treated in units located in California, Alaska, Hawaii, Guam, the Mariana Islands, and American Samoa.ConclusionsWe observed significant regional differences in the outcomes of PD patients in the United States that have not previously been reported. Understanding the differences in clinical practice that underlie these regional differences might help to further improve PD outcomes.


2018 ◽  
Vol 38 (1) ◽  
pp. 73-76
Author(s):  
Colin Lee ◽  
Sandra A.N. Walker ◽  
Lesley Palmay ◽  
Scott E. Walker ◽  
Sheldon Tobe ◽  
...  

Steady-state pharmacokinetics of oral ciprofloxacin in 3 continuous cycling peritoneal dialysis (CCPD) outpatients given ciprofloxacin 750 mg b.i.d. for 5 doses was determined. Mean steady-state maximum serum concentration and half-life were 4.4 ±1.5 mg/L and 10.3 ± 2.6 hours, respectively. Mean maximum dialysate concentration in the daytime long dwell and overnight continuous cycling dwell were 7.4 ± 1.2 mg/L and 3.3 ± 1.2 mg/L, respectively. Oral ciprofloxacin 750 mg b.i.d. may be reasonable for bloodstream and peritoneal infections caused by susceptible bacteria in CCPD patients.


2014 ◽  
Vol 64 (5) ◽  
pp. 761-769 ◽  
Author(s):  
Joseph Pulliam ◽  
Nien-Chen Li ◽  
Franklin Maddux ◽  
Raymond Hakim ◽  
Frederic O. Finkelstein ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document